Phase I and pharimacokinetic trial of a novel inhibitor of NAD biosynthesis in patients with solid tumors.

被引：0
|
作者：
Holen, KD
Bolling, C
Saltz, LB
Graefe, T
Ty, V
Sogo, N
Starkmann, H
Burk, KH
Hollywood, E
Hanauske, AR
机构：
[1] St Georg Hosp, Hamburg, Germany
[2] Univ Wisconsin, Madison, WI USA
[3] MSKCC, New York, NY USA
[4] Fujisawa Pharmaceut Co Ltd, Osaka, Japan
[5] Fujisawa Deutschland GmbH, Munich, Germany
[6] ClinDesci GmbH, Munich, Germany
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6158S / 6158S
页数：1
相关论文
共 50 条
  • [1] A phase I trial of X-396, a novel ALK inhibitor, in patients with advanced solid tumors.
    Horn, Leora
    Infante, Jeffrey R.
    Blumenschein, George R.
    Wakelee, Heather A.
    Arkenau, Hendrik-Tobias
    Dukart, Gary
    Liang, Chris
    Harrow, Kimberly
    Gibbons, Jay
    Lovly, Christine Marie
    Pao, William
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Phase I trial of SU011248, a novel tyrosine kinase inhibitor in advanced solid tumors.
    Rosen, L
    Mulay, M
    Long, J
    Wittner, J
    Brown, J
    Martino, AM
    Bello, CL
    Walter, S
    Scigalla, P
    Zhu, J
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 284S - 284S
  • [3] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [4] A phase I trial of sarcosinamide nitrosourea in adult patients with solid tumors.
    Puchalski, TA
    Eder, JP
    Ryan, DP
    Clark, JW
    Castellana, W
    Garcia-Carbonero, R
    Kufe, DW
    Supko, JG
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3709S - 3709S
  • [5] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] A phase I trial of the novel oral taxane BMS-275183 in patients with advanced solid tumors.
    Broker, LE
    De Vos, FY
    Gall, H
    Gietema, JA
    Voi, M
    Cohen, MB
    De Vries, EG
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 134S - 134S
  • [7] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [8] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [10] Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.
    Eads, Jennifer Rachel
    Krishnamurthi, Smitha S.
    Saltzman, Joel N.
    Bajor, David Lawrence
    Vinayak, Shaveta
    Barnholtz-Sloan, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345